Dra. Laura Domingo Rodriguez

Institutions of which it is part

PhD in Biomedicine with extensive experience in the neuroscience field as a preclinical researcher and complemented as a Clinical Trials Study Coordinator in Movement Disorders unit - VHIR . I am proactive, fast-learning, and well-organized professional. Comfortable working autonomously and in a multidisciplinary teamwork environment. Proven ability to manage with several responsibilities in a fast-paced environment with critical deadlines. I am always motivated to embrace new challenges in my job.

Curriculum

EXPERIENCE
- Clinical Trials Study Coordinator
Movement Disorders Unit - Vall d’Hebron Institute of Research (VHIR) | Sep 2020

- Postdoctoral Researcher in Neuroscience
Neuropharmacology Lab, UPF | Jan - Jun 2020

- PhD Researcher in Biomedicine | Neuroscience
Neuropharmacology Lab, UPF | Sept 2015 - Jan 2020

- University teacher of Psychology of human behavior
UAB Study Abroad Program | Jul 2017 - Jul 2019

EDUCATION
- Master's degree in Clinical Trial Monitoring and Pharmaceutical Development
INESEM Business School | Jul 2020 - Jan 2021

- PhD in Biomedicine (Excellent cum laude)
Neuropharmacology Lab, UPF | Sept 2015 - Jul 2020

- Master’s degree in Neuroscience
Barcelona University | Sept 2014 - Jul 2015

- Bachelor’s degree in Human Biology
Pompeu Fabra University (UPF) | Sept 2010 - Jun 2014

COMPLEMENTARY EDUCATION AND CERTIFICATIONS
- Good Clinical Practice (GCP)
The National Institute on Drug Abuse (NIDA)| May 2020

- Advanced Certificate inEnglish (C1)

MAIN SCIENTIFIC PUBLICATIONS
- Domingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B, Martín-García E, Maldonado R. A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun. 2020 Feb 7;11(1):782.

- Martín-García E, Domingo-Rodriguez L, Maldonado R. An Operant Conditioning Model Combined with a Chemogenetic Approach to Study the Neurobiology of Food Addiction in Mice. Bio Protoc. 2020 Oct 5;10(19):e3777.

- Ruiz de Azua I, Martin-Garcia E, Domingo-Rodriguez L, Aparisi Rey A, Pascual Cuadrado D, Islami L, Turunen P, Remmers F, Lutz B, Maldonado R. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons drives overconsumption of palatable food and obesity. Neuropsychopharmacology. 2021 Apr;46(5):982-991.

- Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Vulnerability to addiction. Neuropharmacology. 2021 Mar 15;186:108466.

- Maldonado R, Calvé P, García-Blanco A, Domingo-Rodriguez L, Senabre E, Martín-García E. Genomics and epigenomics of addiction. Am J Med Genet B Neuropsychiatr Genet. 2021
Laura Domingo Rodriguez

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.